1:apatinib

3 trials

Sponsors

Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Fudan University Shanghai Cancer Center, Jiangsu Cancer Hospital

Conditions

Thyroid canceradvanced gastric cancerhepatocellular carcinoma

Phase 2

Intensity modulated radiation therapy combined with apatinib for inoperable or iodine refractory thyroid cancer, a phase II single-arm study

RecruitingChiCTR-OIN-17011812

Fudan University Shanghai Cancer CenterThyroid cancer

Start: 2017-07-01Updated: 2017-07-03

Phase 4

A prospectiv, multi-center, non-intervention study of Apatinib in the treatment of advanced gastric cancer

RecruitingChiCTR-OPN-15006601

Jiangsu Cancer Hospitaladvanced gastric cancer

Start: 2015-07-01Updated: 2017-04-18

Apatinib in the treatment for advanced Hepatocellular Carcinoma: a prospective, multi-center study

Active, not recruitingChiCTR1900024269

Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technologyhepatocellular carcinoma

Start: 2019-07-15Updated: 2019-07-15

Related Papers

<p>Effectiveness and Safety of Apatinib in Patients with Advanced or Metastatic Adenocarcinoma of Stomach or Gastroesophageal Junction: A Prospective Observation Study</p>

OncoTargets and Therapy2020-05-0110 citations

Identification of patients who benefit from apatinib in advanced gastric cancer: Data derived from a real-world study

Annals of Oncology2018-10-01